How many insider trades does FilingIQ track for CLYM?

FilingIQ tracks 27 Form 4 insider transactions for CLYM (Climb Bio, Inc.), covering filings from Dec 18, 2024 onwards. 3 of those were filed in the last 90 days.

Are CLYM insiders net buyers or net sellers?

Across the full Form 4 history for CLYM, 3 transactions (11%) were open-market purchases and 8 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CLYM insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CLYM in?

Climb Bio, Inc. (CLYM) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $382.51M.

CLYM insider trading

Healthcare

Climb Bio, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

11% / 30%

Market cap

$382.51M

About Climb Bio, Inc.

Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases. The company develops budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug IV for the treatment of primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN). The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts.

Company website: climbbio.com

CLYM insider activity at a glance

FilingIQ has scored 27 insider transactions for CLYM since Dec 18, 2024. The most recent filing in our index is dated Apr 29, 2026.

Across the full history, 3 open-market purchases and 8 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CLYM insider trades is 57.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CLYM trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for CLYM?: FilingIQ tracks 27 Form 4 insider transactions for CLYM (Climb Bio, Inc.), covering filings from Dec 18, 2024 onwards. 3 of those were filed in the last 90 days.
Are CLYM insiders net buyers or net sellers?: Across the full Form 4 history for CLYM, 3 transactions (11%) were open-market purchases and 8 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CLYM insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CLYM in?: Climb Bio, Inc. (CLYM) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $382.51M.

Methodology & sources

Every CLYM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.